Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
Sales | 10,276 | 7,788 | 10,200 | 12,037 | 7,223 |
Cost of Goods | 11,856 | 13,496 | 16,829 | 11,692 | 7,916 |
Gross Profit | -1,579 | -5,708 | -6,630 | 345 | -694 |
Operating Expenses | 13,077 | 11,911 | 10,970 | 8,864 | 9,273 |
Operating Income | -13,801 | -17,124 | -16,770 | -7,827 | -9,050 |
Interest Expense | 3,091 | 3,067 | 2,717 | 2,731 | 2,649 |
Other Income | -25 | 13 | 242 | -3 | 261 |
Pre-tax Income | -16,918 | -20,178 | -19,245 | -10,561 | -11,439 |
Net Income Continuous | -16,918 | -20,178 | -19,245 | -10,561 | -11,439 |
Net Income | $-16,918 | $-20,178 | $-19,245 | $-10,561 | $-11,439 |
EPS Basic Total Ops | -0.19 | -0.23 | -0.26 | -0.17 | -0.19 |
EPS Basic Continuous Ops | -0.19 | -0.23 | -0.26 | -0.16 | -0.19 |
EPS Diluted Total Ops | -0.19 | -0.23 | -0.26 | -0.17 | -0.19 |
EPS Diluted Continuous Ops | -0.19 | -0.23 | -0.26 | -0.16 | -0.19 |
EBITDA(a) | $-12,332 | $-15,829 | $-15,587 | $-6,573 | $-7,889 |